[CNBC Television] ChargePoint shares surging today, but still down from their 52-week high
🎯 Загружено автоматически через бота:
🚫 Оригинал видео:
📺 Данное видео принадлежит каналу «CNBC Television» (@CNBCtelevision). Оно представлено в нашем сообществе исключительно в информационных, научных, образовательных или культурных целях. Наше сообщество не утверждает никаких прав на данное видео. Пожалуйста, поддержите автора, посетив его оригинальный канал.
✉️ Если у вас есть претензии к авторским правам на данное видео, пожалуйста, свяжитесь с нами по почте support@, и мы немедленно удалим его.
📃 Оригинальное описание:
ChargePoint CEO Pasquale Romano joins The Exchange to discuss his company’s position as a tech stock and why he’s still bullish on the electric vehicle market. For access to live and exclusive video from CNBC subscribe to CNBC PRO:
ChargePoint, which makes charging systems for electric vehicles, soared more than 13% in extended trading after reporting quarterly revenue of $56.1 million, compared to the $49.1 million expected. The company also gave strong third-quarter and full-year revenue guidance.
» Subscribe to CNBC TV:
» Subscribe to CNBC:
» Subscribe to CNBC Classic:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30:
Connect with CNBC News Online
Get the latest news:
Follow CNBC on LinkedIn:
Follow CNBC News on Facebook:
Follow CNBC News on Twitter:
Follow CNBC News on Instagram:
#CNBC
#CNBCTV
1 view
0
0
1 week ago 00:03:30 1
[CNBC Television] Two experts discuss what happens to inflation in 2023
1 week ago 00:01:55 1
[CNBC Television] Coronavirus: Here’s an inside look at General Motors’ face mask plant
1 week ago 00:07:10 1
[CNBC Television] GSK CEO: Pfizer venture creates value for both our consumer and pharma businesses